Related Experiment Video
Updated: Jun 17, 2026

05:58
Large Volume 20L+ Filtration of Coastal Seawater Samples
Published on: June 18, 2009
11.9K
Scale-up issues for commercial depth filters in bioprocessing
Negin Nejatishahidein1, Minyoung Kim1, Seon Y Jung1,2
1Department of Chemical Engineering, The Pennsylvania State University, University Park, Pennsylvania, USA.
Biotechnology and Bioengineering
|January 15, 2022
Summary
Computational fluid dynamics (CFD) revealed differing flow distributions in lab-scale and pilot-scale depth filter modules. This explains performance variations and aids in optimizing depth filtration for antibody production.
Area of Science:
- Bioprocessing and Pharmaceutical Manufacturing
- Chemical Engineering and Fluid Dynamics
- Filtration Technology
Background:
- Depth filtration is crucial for clarifying cell culture fluid in antibody production.
- Filter performance depends on internal pressure and velocity, which are challenging to measure experimentally.
- Scale-up of depth filtration processes faces challenges due to complex flow dynamics.
Purpose of the Study:
- To investigate the impact of flow distribution on depth filter performance during antibody production.
- To compare the hydrodynamics and performance of lab-scale and pilot-scale depth filter modules.
- To utilize computational fluid dynamics (CFD) to explain and predict filter behavior and facilitate scale-up.
Main Methods:
- Employed a combination of experimental studies and CFD simulations.
- Analyzed dual-layer lenticular PDH4 media depth filters in Supracap™ 50 (lab-scale) and Stax™ (pilot-scale) modules.
- Validated CFD predictions using residence time distribution and dye binding measurements.
Main Results:
- Observed more rapid transmembrane pressure increase and DNA breakthrough in the Supracap™ 50 module.
- CFD calculations revealed distinct flow distributions within the lab-scale and pilot-scale modules, explaining the experimental observations.
- Experimental validation confirmed the accuracy of CFD predictions for flow dynamics.
Conclusions:
- Flow distribution significantly impacts depth filter performance and scale-up in antibody production.
- CFD modeling provides valuable insights into filter hydrodynamics, aiding process design and optimization.
- The developed framework can enhance the design of future depth filters and filtration processes.
Related Concept Videos
Bioreactor Design and Operational System
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
Designing Growth Media for Bioreactors
Growth media provide essential nutrients that support cell growth and metabolism, thereby enhancing the yield of valuable products such as enzymes, antibiotics, and biomass. Designing an effective growth medium involves balancing all components to prevent nutrient limitations or toxic excesses, both of which can impair growth and reduce product yields.Composition of a Typical Growth MediumA typical growth medium contains carbon and nitrogen sources, salts, vitamins, trace elements, and...
Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

